Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Lucira Health, Inc. LHDX
$0.45
На 18:04, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
18362928.00000000
-
week52high
4.35
-
week52low
0.11
-
Revenue
93055000
-
P/E TTM
0
-
Beta
3.75954000
-
EPS
-3.14000000
-
Last Dividend
0.00000000
-
Next Earnings Date
10 мая 2023 г. в 10:59
Описание компании
Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Chemical Co., Ltd.; technical services agreement with Jabil, Inc.; and manufacturing services agreement with Jabil MSA. The company was formerly known as DiAssess Inc. and changed its name to Lucira Health, Inc. in January 2020. Lucira Health, Inc. was incorporated in 2013 and is headquartered in Emeryville, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| William Blair | Market Perform | Outperform | 04 мая 2021 г. |
| B of A Securities | Underperform | Buy | 13 апр 2021 г. |
| William Blair | Outperform | 02 мар 2021 г. | |
| B of A Securities | Neutral | 02 мар 2021 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Allen Anthony Joseph | D | 144925 | 4263 | 20 дек 2022 г. |
| EPIQ Capital Group, LLC | A | 1014593 | 725675 | 14 дек 2022 г. |
| EPIQ Capital Group, LLC | A | 288918 | 256742 | 14 дек 2022 г. |
| EPIQ Capital Group, LLC | D | 32176 | 735475 | 14 дек 2022 г. |
| EPIQ Capital Group, LLC | D | 767651 | 5173026 | 14 дек 2022 г. |
| EPIQ Capital Group, LLC | D | 5940677 | 3754084 | 14 дек 2022 г. |
| EPIQ Capital Group, LLC | D | 9694761 | 3461764 | 14 дек 2022 г. |
| Narido Richard Clavano | D | 107293 | 1583 | 01 дек 2022 г. |
| Kashmolah Ghazi | D | 139103 | 7537 | 28 ноя 2022 г. |
| Collins Kevin Walter | D | 346722 | 9666 | 27 ноя 2022 г. |
Новостная лента
5 Big Winners as Wall Street Wraps Up Strong January Gains
Zacks Investment Research
01 февр 2023 г. в 09:47
AppHarvest (APPH), Lucira Health (LHDX), Lucid Group (LCID), Life Time Group (LTH) & Ameriprise Financial (AMP) not only have made the most of the January rally but also are poised to gain further this year.
Biggest Penny Stocks Trading Mistakes to Avoid in 2023
PennyStocks
04 янв 2023 г. в 06:00
Avoid making these penny stocks trading mistakes this year The post Biggest Penny Stocks Trading Mistakes to Avoid in 2023 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Why Lucira Health (LHDX) Stock Up 400% Today?
InvestorPlace
03 янв 2023 г. в 15:15
One of the biggest upside movers in today's upside-down market is medical technology company Lucira Health (NASDAQ: LHDX ). This little-known maker of PCR tests for various infectious diseases is on a tear, with LHDX stock up more than 400% as of early afternoon trading.
Lucira Health, Inc. (LHDX) Q3 2022 Earnings Call Transcript
Seeking Alpha
14 ноя 2022 г. в 19:05
Lucira Health, Inc. (NASDAQ:LHDX ) Q3 2022 Earnings Conference Call November 14, 2022 4:30 PM ET Company Participants Greg Chodaczek – Gilmartin Group Erik Engelson – President and Chief Executive Officer Dan George – Chief Financial Officer Conference Call Participants Operator Good afternoon, ladies and gentlemen, and welcome to the Lucira Health Third Quarter 2022 Earnings Conference Call. At this time all participants are in a listen-only mode.
Lucira Health to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase
GlobeNewsWire
23 авг 2022 г. в 07:00
EMERYVILLE, Calif., Aug. 23, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that the company will participate in the Gilmartin Group Emerging Growth Company Showcase on August 31st, 2022.